Abolition of specific immune response defect by immunization with dendritic cells
Claire J. P. Boog(The Netherlands Cancer Institute), Cornelis J.M. Melief(Leiden University), W. Martin Kast(University of Southern California), H. T. Marc Timmers(University of Freiburg), Jolande Boes(Dutch Blood Transfusion Society), Leo P. de Waal
Cited by 66
Related Papers
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells
|Nature Medicine|2002|549